| Purpose of the guideline: |
Hepatic encephalopathy (HE) is mostly induced by infection. Internal inflammation can be caused by intestinal bacterial translocation or elevated endotoxin levels, even without evident infectious lesions. Therefore, the treatment principals of HE are supposed to be, timely removal of triggers, elimination of internal inflammation, regulation of intestinal flora, and restoration of intestinal homeostasis. This article is to provide recommended suggestions for clinical usage of antibacterial drugs and intestinal microbiota preparations including rifamycins, minoglycosides and nitroimidazoles in management of HE. |
